RESEARCH experts and charities working with people with serious and often terminal illnesses have said that delays to research and clinical trials from Brexit could mean the difference between "life or death" for patients.

The warning comes after a Glasgow-based, world-leading cancer expert said he was considering moving a major research project abroad because of a Brexit-linked impasse over EU funding.

Scientific leaders have urged the government not to abandon talks to enable the UK to participate in a €100bn European research programme.

Four international scientists explain how a grant debacle stemming from Brexit has affected their research and career plans. / UK science suffered a significant setback in June, when the European Research Council (ERC) confirmed that 143 UK-based researchers would forfeit their prestigious ERC grants unless they relocated to a country in the European Union.

So how would a no-deal Brexit affect cancer patients and research?